N/A
N=42
Mobile Health Intervention for Active Tuberculosis
Tuberculosis · Adherence, Medication
Bottom Line
View on ClinicalTrials.gov: NCT03544476 ↗Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Number of Participants With Treatment Success — 20; 17 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Mobile phone TB treatment support app plus usual care (Behavioral); Usual care (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Mar 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Treatment Success |
20; 17 | — |
| SECONDARY Engagement: Average Number of Days Participants Reported Through the App |
147.2 | — |
Summary
The purpose of this study is to evaluate and further refine a mobile support tool for patients receiving treatment for active tuberculosis. Half of participants will receive support and monitoring using a mobile phone software application and usual care, while the other half will receive usual care.
Eligibility Criteria
Inclusion Criteria
- Subject is starting TB treatment for the first time
- Subject has no known TB drug resistance
- Subject is HIV negative (self-reported or documented)
- Subject owns or has regular access to a mobile phone that can access the Internet and is able to operate the mobile phone to communicate or have someone able to assist.
Exclusion Criteria
- Severely ill (i.e., requiring hospitalization)
- Reside in the same household with another study participant
- History of known drug resistance and HIV co-infection because their care is managed separately and the treatment regimens and duration differ.
Data sourced from ClinicalTrials.gov (NCT03544476). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.